Biotech Inv Fund

Monitored: 5157 day(s) since 02-14-2010
Updated: 03/12/2012 18:19
Site features: SSL Whois DDOS 
NOT PAYING
HYIP BiotechInvFund screenshot home page
Biotech Inv Fund screenshot actual 14-02-10
Deposit min/max: $5 / $50.000
Profit:
Withdrawal: Manual
Referral: 10% per each deposit
Monitored Plan:
Our investment: $100
Daily payout: $180 calendar
ROI: not in profit
Investors rate: rating point rating point rating point rating point rating point
Overall rating: rating point rating point rating point rating point rating point

BiotechInvFund.com is the subsidiary of Bio Aspects Inc. is an international investment group dedicated exclusively to the life sciences and healthcare sectors. Since its founding in 2006, Bio Aspects Inc. has formed six venture capital funds, which total over $27 million and have invested in more than 136 biotech companies.

e-currency logo  

Support page: http://support.biotechinvfund.com/
E-mail: [email protected]
Phone:  phone  +44 (0) 871 245 6591
The analytics given below gives visual image of the correlation ratio between deposits to interest payouts and profit earned, as well as the dates and amounts of dividends payments.
Biotech Inv Fund payments history Biotech Inv Fund investment perfomance
Below we quote some information from the site of their business principles and history.
OVERVIEW:
Our specialist team of over 20 professionals has a broad range of skills, including scientific and medical expertise as well as investment, banking and legal knowledge. Our executive and advisory network`s broad scientific and medical experience allow us to identify the most promising financial opportunities that exist in biotech industry.

Our management team

Our management team is comprised of a deliberately small, but highly qualified and experienced core group of professionals who provide an outstanding blend of scientific and investment expertise, and a proven track record of delivering superb results for our investors.

David Foreman, M.D., Ph.D. founder

David Foreman is the founder and managing director of Bio Aspects Inc. Doctor David Foreman has full-cycle investing experience, successfully sourcing, syndicating, managing and exiting investments. He graduated from Mount Sinai School of Medicine and received his Ph.D. in Biomedical Engineering from Columbia University. He received his M.B.A. from Columbia School of Business. Dr. Foreman holds a B.S. in Chemical Engineering and a B.S. in Biological Sciences.

Francis Newman co-founder

Francis Newman, is the co-founder and the senior partner of Bio Aspects Inc. Dr. Newman has a background as a biotech entrepreneur, biotech intellectual property rights expert and business development executive, combined with a scientific career. He has been actively involved in biotech investment since the late 1990`s. Dr. Newman holds an MSc in chemical engineering, a PhD in molecular biology biochemistry and an MBA.

Vera Schormann, Scientific advisor

Ms. Schormann has a strong background in chemical research and analysis, and a superb track record of successful project leadership. She received her M.Sc. in Pharmaceutical Sciences from the University of Greenwich, and her B.Sc. in Chemistry from the University of Guelph.

Howard Sumner, Investment expert

Howard Sumner has been the investment expert of Bio Aspects Inc. since the company formation in 2005. Howard has over 20 years of experience in private equity and investment banking. He has in-depth experience investing in healthcare industry throughout his career. Mr. Howard holds a BA and a MBA from Cornell University.